Local treatment options for ipsilateral breast tumour recurrence

被引:27
作者
Hannoun-Levi, Jean-Michel [1 ]
Ihrai, Tarik [2 ]
Courdi, Adel [1 ]
机构
[1] Univ Nice Sophia Antipolis, Antoine Lacassagne Canc Ctr, Dept Radiat Therapy, F-06189 Nice, France
[2] Univ Nice Sophia Antipolis, Antoine Lacassagne Canc Ctr, Dept Surg Oncol, F-06189 Nice, France
关键词
Breast cancer; Local recurrence; Conservative treatment; 2ND CONSERVATIVE TREATMENT; 20-YEAR FOLLOW-UP; SALVAGE MASTECTOMY; CANCER RECURRENCE; RADIATION-THERAPY; INTERSTITIAL BRACHYTHERAPY; CONSERVING SURGERY; CHEST-WALL; IRRADIATION; LUMPECTOMY;
D O I
10.1016/j.ctrv.2013.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: In case of ipsilateral breast tumour recurrence (IBTR), radical mastectomy represents the treatment option frequently proposed. A second conservative treatment (2ndCT) has been proposed using either lumpectomy alone or associated with a re-irradiation of the tumor bed. However, in both clinical situations, the proof level of such therapeutic approaches remains low, based on cased-series or retrospective studies (level C). Material and methods: In order to assess the different strategies of local treatment proposed in case of IBTR, a PubMed literature review was performed using the following keywords: breast cancer, ipsilateral recurrence, mastectomy, radiation therapy, brachytherapy. Four different salvage options were analyzed: (a) salvage mastectomy alone; (b) salvage mastectomy with postoperative re-irradiation; (c) 2ndCT with surgery alone; (d) 2ndCT with re-irradiation. Results: The rate of second local recurrence is about 10% [3-32%], about 25% [7-36%] and about 10% [2-26%], after salvage mastectomy, salvage lumpectomy alone or combined with a re-irradiation of the tumor bed respectively. Results: However, the 5-year overall survival rates after salvage mastectomy and 2ndCT seem to be equivalent (approximate to 175%) mainly influenced by distant metastatic progression. Conclusion: In terms of Evidence Based Medicine, different options can be discussed such as Phase III or II randomized trials comparing salvage mastectomy versus 2ndCT, retrospective studies based on a matched-pair analysis or observatory studies. Those study designs need to be carefully analyzed to be able to propose new treatment options for women who experience an IBCR. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:737 / 741
页数:5
相关论文
共 40 条
[1]   PROGNOSIS FOLLOWING SALVAGE MASTECTOMY FOR RECURRENCE IN THE BREAST AFTER CONSERVATIVE SURGERY AND RADIATION-THERAPY FOR EARLY-STAGE BREAST-CANCER [J].
ABNER, AL ;
RECHT, A ;
EBERLEIN, T ;
COME, S ;
SHULMAN, L ;
HAYES, D ;
CONNOLLY, JL ;
SCHNITT, SJ ;
SILVER, B ;
HARRIS, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) :44-48
[2]   Ipsilateral breast tumor recurrence after breast conservation therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation [J].
Alpert, TE ;
Kuerer, HM ;
Arthur, DW ;
Lannin, DR ;
Haffty, BG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03) :845-851
[3]  
[Anonymous], 1014 RTOG
[4]   High-resolution mapping of DNA breakpoints to define true recurrences among lpsilateral breast cancers [J].
Bollet, Marc A. ;
Servant, Nicolas ;
Neuvial, Pierre ;
Decraene, Charles ;
Lebigot, Ingrid ;
Meyniel, Jean-Philippe ;
De Rycke, Yann ;
Savignoni, Alexia ;
Rigaill, Guillem ;
Hupe, Philippe ;
Fourquet, Alain ;
Sigal-Zafrani, Brigitte ;
Barillot, Emmanuel ;
Thiery, Jean-Paul .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (01) :48-58
[5]   FIRST ISOLATED LOCOREGIONAL RECURRENCE FOLLOWING MASTECTOMY FOR BREAST-CANCER - RESULTS OF A PHASE-III MULTICENTER STUDY COMPARING SYSTEMIC TREATMENT WITH OBSERVATION AFTER EXCISION AND RADIATION [J].
BORNER, M ;
BACCHI, M ;
GOLDHIRSCH, A ;
GREINER, R ;
HARDER, F ;
CASTIGLIONE, M ;
JUNGI, WF ;
THURLIMANN, B ;
CAVALLI, F ;
OBRECHT, JP ;
LEYVRAZ, S ;
ALBERTO, P ;
ADAM, H ;
VARINI, M ;
LOEHNERT, T ;
SENN, HJ ;
METZGER, U ;
BRUNNER, K .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2071-2077
[6]   Residual risk of breast cancer recurrence 5 years after adjuvant therapy [J].
Brewster, Abenaa M. ;
Hortobagyi, Gabriel N. ;
Broglio, Kristine R. ;
Kau, Shu-Wan ;
Santa-Maria, Cesar A. ;
Arun, Banu ;
Buzdar, Arnan U. ;
Booser, Daniel J. ;
Valero, Vincente ;
Bondy, Melissa ;
Esteva, Francisco J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) :1179-1183
[7]  
CAJUCOM CC, 1993, CANCER, V71, P1774, DOI 10.1002/1097-0142(19930301)71:5<1774::AID-CNCR2820710511>3.0.CO
[8]  
2-V
[9]   The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer [J].
Chadha, Manjeet ;
Feldman, Sheldon ;
Boolbol, Susan ;
Wang, Lin ;
Harrison, Louis B. .
BRACHYTHERAPY, 2008, 7 (01) :22-28
[10]   The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence [J].
Chen, Steven L. ;
Martinez, Steve R. .
AMERICAN JOURNAL OF SURGERY, 2008, 196 (04) :495-499